IL-23 from langerhans cells is required for the development of imiquimod-induced psoriasis-like dermatitis by induction of IL-17A-producing γδ T cells

Journal of Investigative Dermatology

Volumn 134, Issue 7, 2014, Pages 1912-1921

  Yoshiki, Ryutaro ^a   Kabashima, Kenji ^b   Honda, Tetsuya ^b   Nakamizo, Satoshi ^b   Sawada, Yu ^b   Sugita, Kazunari ^a   Yoshioka, Haruna ^a   Ohmori, Shun ^a   Malissen, Bernard ^c   Tokura, Yoshiki ^d   Nakamura, Motonobu ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c CNRS   (France)

^d HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR6; DIPHTHERIA TOXIN; IMIQUIMOD; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 22; INTERLEUKIN 23; INTERLEUKIN 23P19; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DERMATITIS; GAMMA DELTA T LYMPHOCYTE; HYPERKERATOSIS; LANGERHANS CELL; MOUSE; NONHUMAN; PARAKERATOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS; PSORIASIS LIKE DERMATITIS; TH17 CELL;

ADJUVANTS, IMMUNOLOGIC; AMINOQUINOLINES; ANIMALS; DERMATITIS, CONTACT; DISEASE MODELS, ANIMAL; INTERLEUKIN-12; INTERLEUKIN-17; INTERLEUKIN-23 SUBUNIT P19; INTERLEUKINS; LANGERHANS CELLS; LYMPH NODES; MICE; MICE, INBRED C57BL; ORGAN CULTURE TECHNIQUES; PSORIASIS; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; RECEPTORS, CCR6; RNA, MESSENGER; SKIN; TRANSPLANTATION CHIMERA;

EID: 84902537284     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2014.98     Document Type: Article

References (36)

1. Bennett CL, Noordegraaf M, Martina CA et al. (2007) Langerhans cells are required for efficient presentation of topically applied hapten to T cells. J Immunol 179: 6830-5
2. Boyman O, Hefti HP, Conrad C et al. (2004) Spontaneous development of psoriasis in a new animal model shows an essential role for resident T cells and tumor necrosis factor-alpha. J Exp Med 199: 731-6
3. Bursch LS, Wang L, Igyarto B et al. (2007) Identification of a novel population of Langerin+ dendritic cells. J Exp Med 204: 3147-56
4. Cai Y, Shen X, Ding C et al. (2011) Pivotal role of dermal IL-17-producing gammadelta T cells in skin inflammation. Immunity 596-610
5. Capon F, Di Meglio P et al. (2007) Sequence variants in the genes for the interleukin-23 receptor (IL23R) and its ligand (IL12B) confer protection against psoriasis. Hum Genet 122: 201-6
6. Chan JR, Blumenschein W, Murphy E et al. (2006) IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis. J Exp Med 203: 2577-87
7. Cua DJ, Sherlock J, Chen Y et al. (2003) Interleukin-23 rather than interleukin- 12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421: 744-8
8. Cua DJ, Tato CM (2010) Innate IL-17-producing cells: the sentinels of the immune system. Nat Rev Immunol 10: 479-89
9. Di Cesare A, Di Meglio P, Nestle FO (2009) The IL-23/Th17 axis in the immunopathogenesis of psoriasis. J Invest Dermatol 129: 1339-50
10. Diveu C, McGeachy MJ, Cua DJ (2008) Cytokines that regulate autoimmunity. Curr Opin Immunol 20: 663-8
11. Egawa G, Kabashima K (2011) Skin as a peripheral lymphoid organ: revisiting the concept of skin-associated lymphoid tissues. J Invest Dermatol 131: 2178-2178
12. Fanti PA, Dika E, Vaccari S et al. (2006) Generalized psoriasis induced by topical treatment of actinic keratosis with imiquimod. Int J Dermatol 45: 1464-1464
13. Ferenczi K, Burack L, Pope M et al. (2000) CD69, HLA-DR and the IL-2R identify persistently activated T cells in psoriasis vulgaris lesional skin: blood and skin comparisons by flow cytometry. J Autoimmun 14:q63-78
14. Ginhoux F, Collin MP, Bogunovic M et al. (2007) Blood-derived dermal langerin+ dendritic cells survey the skin in the steady state. J Exp Med 204: 3133-46
15. Hasegawa E, Sonoda KH, Shichita T et al. (2013) IL-23-independent induction of IL-17 from gammadeltaT cells and innate lymphoid cells promotes experimental intraocular neovascularization. J Immunol 190: 1778-87
16. Honda T, Egawa G, Grabbe S et al. (2012) Update of immune events in the murine contact hypersensitivity model: toward the understanding of allergic contact dermatitis. J Invest Dermatol 133: 303-15
17. Igyarto BZ, Haley K, Ortner D et al. (2011) Skin-resident murine dendritic cell subsets promote distinct and opposing antigen-specific T helper cell responses. Immunity 35: 260-72
18. Iizuka H (1994) Epidermal turnover time. J Dermatol Sci 8: 215-7
19. Kaplan DH, Igyarto BZ, Gaspari AA (2012) Early immune events in the induction of allergic contact dermatitis. Nat Rev Immunol 12: 114-24
20. Kaplan DH, Jenison MC, Saeland S et al. (2005) Epidermal langerhans celldeficient mice develop enhanced contact hypersensitivity. Immunity 23: 611-20
21. Kissenpfennig A, Henri S, Dubois B et al. (2005) Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity 22: 643-54
22. Krueger GG, Langley RG, Leonardi C et al. (2007) A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis. N Engl J Med 356: 580-92
23. Kryczek I, Bruce AT, Gudjonsson JE et al. (2008) Induction of IL-17+ T cell trafficking and development by IFN-gamma: mechanism and pathological relevance in psoriasis. J Immunol 181: 4733-41
24. Lee E, Trepicchio WL, Oestreicher JL et al. (2004) Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris. J Exp Med 199: 125-30
25. Lowes MA, Kikuchi T, Fuentes-Duculan J et al. (2008) Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J Invest Dermatol 128: 1207-11
26. Mabuchi T, Takekoshi T, Hwang ST (2011) Epidermal CCR6+ gammadelta T cells are major producers of IL-22 and IL-17 in a murine model of psoriasiform dermatitis. J Immunol 187: 5026-31
27. Merad M, Hoffmann P, Ranheim E et al. (2004) Depletion of host Langerhans cells before transplantation of donor alloreactive T cells prevents skin graft-versus-host disease. Nat Med 10: 510-7
28. Nograles KE, Zaba LC, Guttman-Yassky E et al. (2008) Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte- response pathways. Br J Dermatol 159: 1092-102
29. Roller A, Perino A, Dapavo P et al. (2012) Blockade of phosphatidylinositol 3- kinase (PI3K)delta or PI3Kgamma reduces IL-17 and ameliorates imiquimod- induced psoriasis-like dermatitis. J Immunol 189: 4612-20
30. Romani N, Clausen BE, Stoitzner P (2010) Langerhans cells and more: langerin-expressing dendritic cell subsets in the skin. Immunol Rev 234: 120-41
31. Suzuki H, Wang B, Shivji GM et al. (2000) Imiquimod, a topical immune response modifier, induces migration of Langerhans cells. J Invest Dermatol 114: 135-41
32. Tokura Y, Yagi J, O'Malley M et al. (1994) Superantigenic staphylococcal exotoxins induce T-cell proliferation in the presence of Langerhans cells or class II-bearing keratinocytes and stimulate keratinocytes to produce T-cell-activating cytokines. J Invest Dermatol 102: 31-8
33. van der Fits L, Mourits S, Voerman JS et al. (2009) Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis. J Immunol 182: 5836-45
34. Walter A, Schafer M, Cecconi V et al. (2013) Aldara activates TLR7- independent immune defence. Nat Commun 4:1560
35. Wohn C, Ober-Blobaum JL, Haak S et al. (2013) Langerin(neg) conventional dendritic cells produce IL-23 to drive psoriatic plaque formation in mice. Proc Natl Acad Sci USA 110: 10723-8
36. Zaba LC, Cardinale I, Gilleaudeau P et al. (2007) Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses. J Exp Med 204: 3183-94